Quote | Rallybio Corporation (NASDAQ:RLYB)
Last: | $1.20 |
---|---|
Change Percent: | -2.21% |
Open: | $1.39 |
Close: | $1.20 |
High: | $1.42 |
Low: | $1.155 |
Volume: | 714,816 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Rallybio Corporation (NASDAQ:RLYB)
– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk for FNAIT Annually and the RLYB212 Addressable Market – ...
2024-05-31 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Morgan Stanley recently released its bullish take on the biotech space, driven by anticipated interest rate cuts and a surge in mergers and acquisitions (M&A) activity. The analyst firm...
Message Board Posts | Rallybio Corporation (NASDAQ:RLYB)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk for FNAIT Annually and the RLYB212 Addressable Market – ...
- On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 2H 2024 - - $94.2 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2024; Provides Runway into Mid-2026 - Rallybio Corporation (Nasdaq: RLYB), a...